# A Study of IOV-5001 in Adults With Advanced Solid Tumors

> **NCT07743723** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Iovance Biotherapeutics, Inc.** · enrollment: 106 (estimated)

## Conditions studied

- Advanced Solid Tumors
- Non-Small Cell Lung Cancer
- Triple Negative Breast Cancer (TNBC)
- Colorectal Cancer
- Head and Neck Squamous Cell Carcinoma
- Metastatic Solid Tumors
- Unresectable Solid Tumor

## Interventions

- **BIOLOGICAL:** IOV-5001

## Key facts

- **NCT ID:** NCT07743723
- **Lead sponsor:** Iovance Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2034-03
- **Final completion:** 2044-03
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2026-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743723, "A Study of IOV-5001 in Adults With Advanced Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*